Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Scully

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Toxins|November 10, 2011
ADAM-15 disintegrin-like domain structure and functionDong Lu, Mike Scully, Vijay Kakkar, et al.
Current Cancer Drug Targets|December 17, 2008
ADAM proteins - therapeutic potential in cancerXinjie Lu, Dong Lu, Mike Scully, et al.
Perspectives in Medicinal Chemistry|September 30, 2009
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapyXinjie Lu, Dong Lu, Mike Scully, et al.
Journal of Substance Abuse Treatment|December 31, 2003
Specialized drug liaison midwife services for pregnant opioid dependent women in Dublin, IrelandMike Scully, Noreen Geoghegan, Paul Corcoran, et al.
International Journal of Cardiology|May 3, 2003
Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunctionFerruccio De Lorenzo, Han Xiao, Zbigniew Kadziola, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 25, 2003
Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunctionFerruchio De Lorenzo, Han Xiao, Mike Scully, et al.
Thrombosis and Haemostasis|November 3, 2006
Integrin binding characteristics of the disintegrin-like domain of ADAM-15Dong Lu, Kian Fan Chung, Min Xia, et al.
Thrombosis and Haemostasis|February 8, 2003
Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosisHans K Breddin, Zbigniew Kadziola, Mike Scully, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosisRemedios Otero, Teresa Elias, Ana Montes-Worboys, et al.
Blood|March 6, 2002
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosisVijay V Kakkar, Debra A Hoppenstead, Jawed Fareed, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Toxins|November 10, 2011
ADAM-15 disintegrin-like domain structure and functionDong Lu, Mike Scully, Vijay Kakkar, et al.
Current Cancer Drug Targets|December 17, 2008
ADAM proteins - therapeutic potential in cancerXinjie Lu, Dong Lu, Mike Scully, et al.
Perspectives in Medicinal Chemistry|September 30, 2009
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapyXinjie Lu, Dong Lu, Mike Scully, et al.
Journal of Substance Abuse Treatment|December 31, 2003
Specialized drug liaison midwife services for pregnant opioid dependent women in Dublin, IrelandMike Scully, Noreen Geoghegan, Paul Corcoran, et al.
International Journal of Cardiology|May 3, 2003
Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunctionFerruccio De Lorenzo, Han Xiao, Zbigniew Kadziola, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 25, 2003
Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunctionFerruchio De Lorenzo, Han Xiao, Mike Scully, et al.
Thrombosis and Haemostasis|November 3, 2006
Integrin binding characteristics of the disintegrin-like domain of ADAM-15Dong Lu, Kian Fan Chung, Min Xia, et al.
Thrombosis and Haemostasis|February 8, 2003
Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosisHans K Breddin, Zbigniew Kadziola, Mike Scully, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosisRemedios Otero, Teresa Elias, Ana Montes-Worboys, et al.
Blood|March 6, 2002
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosisVijay V Kakkar, Debra A Hoppenstead, Jawed Fareed, et al.
Pageof 2